NCT01856920: A trial that was reported late by NantCell, Inc.
This trial has reported, although it was 1806 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01856920 |
|---|---|
| Title | A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 26, 2013 |
| Completion date | May 8, 2018 |
| Required reporting date | May 8, 2019, midnight |
| Actual reporting date | April 17, 2024 |
| Date last checked at ClinicalTrials.gov | May 12, 2025 |
| Days late | 1806 |